Pivotal Therapeutics Inc.
Limited financial coverage for PVTTF.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Pivotal Therapeutics Inc. is a specialized pharmaceutical firm primarily dedicated to addressing cardiovascular ailments and promoting general well-being. The company's flagship offering, VASCAZEN, is a medical food available by prescription only.
- CEO
- Rachelle MacSweeney
- IPO
- 2012
- HQ
- Woodbridge, ON, CA
Get TickerSpark's AI analysis on PVTTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -79.54
- RSI (14)
- 100
- Avg Volume
- 0
No earnings-call transcripts are available for PVTTF yet.
- Free Float
- 65.4%
- Shares Outstanding
- 95.79M
- Float Shares
- 62.62M
Our PVTTF coverage
Recent articles, reports, and earnings notes.
No research on PVTTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PVTTF report →Analyzing Collegium Pharmaceutical (NASDAQ:COLL) and Pivotal Therapeutics (OTCMKTS:PVTTF)
defenseworld.net · Jan 28
Contrasting Nektar Therapeutics (NASDAQ:NKTR) & Pivotal Therapeutics (OTCMKTS:PVTTF)
defenseworld.net · Dec 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.